Decentralized Oncology Trials: Interview with Dr. Crystal S. Denlinger, CSO at NCCN
XTalks
APRIL 10, 2023
The adoption of decentralized clinical trial (DCT) approaches has increased exponentially. Tools such as electronic consent, telehealth appointments and wearable devices have enabled investigators to contact trial participants virtually. Her work now focuses on leading NCCN’s Oncology Research Program ( ORP ), among other duties.
Let's personalize your content